Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
RResMed Inc. logo
RMDNYSE

ResMed Inc.

ResMed Inc.
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Aug 13
Ex-dividend Time TBD
Ex-dividend (predicted) $0.6
Add to Google Calendar
Aug 10
Filing Time TBD
Annual report (10-K) filing due (est.)
Add to Google Calendar
Aug 6
Earnings 16:30
Earnings announcement (通期)
Add to Google Calendar
Earnings 16:30
Earnings call (通期)
Add to Google Calendar
Earnings Time TBD
Full-year earnings
Add to Google Calendar
Apr 30
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Jan 29
Earnings Time TBD
Q2 earnings
Add to Google Calendar
2025
Oct 30
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Jul 31
Earnings Time TBD
Full-year earnings
Add to Google Calendar
Apr 23
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Oct 29
Est.
Earnings 16:05 approx.
Q1 earnings (predicted)
Add to Google Calendar
Oct 30
Est.
Filing Time TBD
Quarterly report (10-Q) filing due (est.)
Add to Google Calendar
Nov 12
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $0.6
Add to Google Calendar
Nov 20
Est.
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar
2027
Jan 21
Est.
Earnings 16:05 approx.
Q2 earnings (predicted)
Add to Google Calendar

KPI highlights

FY25
Revenue $5.15B YoY +9.8%
Operating income $1.69B margin 32.7%
Net income $1.40B YoY +37.2%
EPS $9.55 YoY +37.6%
P/E 18.5× Fair Rough PER guide (a simplified band — fair value varies by industry and growth stage): <10 Cheap / 10–15 Slightly cheap / 15–22 Fair / 22–35 Slightly rich / ≥35 Rich
ROE 23.5% Equity ratio 73% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 1,2821,2921,3481,3361,4231,431
Operating income 417426457462498500
Net income 345365380349393399
Operating CF 348431441443437490

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2013–2026）

機関投資家 63.5%未開示 36.2%20132015201720192021202320252026
機関投資家 63.5%未開示 36.2%13Q114Q215Q316Q418Q119Q220Q321Q423Q124Q225Q426Q1
機関投資家その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

BlackRock, Inc. 8%BlackRock, Inc.VANGUARD CAPITAL M 6.2%VANGUARD CAPITAL MANAGEMENT LLCVANGUARD PORTFOLIO 5.2%VANGUARD PORTFOLIO MANAGEMENT LLCSTATE STREET CORP 4.4%STATE STREET CORPBank of New York M 3.2%Bank of New York Mellon CorpGEODE CAPITAL MANA 2.9%GEODE CAPITAL MANAGEMENT, LLCMORGAN STANLEY 1.8%MORGAN STANLEYInvesco Ltd. 1.3%Invesco Ltd.NORTHERN TRUST COR 1.1%NORTHERN TRUST CORP20132015201720192021202320252026
BlackRock, Inc. 8%BlackRock, Inc.VANGUARD CAPITAL M 6.2%VANGUARD CAPITAL MANAGEMENT LLCVANGUARD PORTFOLIO 5.2%VANGUARD PORTFOLIO MANAGEMENT LLCSTATE STREET CORP 4.4%STATE STREET CORPBank of New York M 3.2%Bank of New York Mellon CorpGEODE CAPITAL MANA 2.9%GEODE CAPITAL MANAGEMENT, LLCMORGAN STANLEY 1.8%MORGAN STANLEYInvesco Ltd. 1.3%Invesco Ltd.NORTHERN TRUST COR 1.1%NORTHERN TRUST CORP13Q114Q215Q316Q418Q119Q220Q321Q423Q124Q225Q426Q1

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
その他機関投資家（13F 899社） 29,691,832 19.6% 13F
BlackRock, Inc. 12,094,023 8.0% 13F
VANGUARD CAPITAL MANAGEMENT LLC 9,466,416 6.2% 13F
VANGUARD PORTFOLIO MANAGEMENT LLC 7,863,922 5.2% 13F
STATE STREET CORP 6,643,168 4.4% 13F
Bank of New York Mellon Corp 4,925,386 3.2% 13F
GEODE CAPITAL MANAGEMENT, LLC 4,352,873 2.9% 13F
MORGAN STANLEY 2,686,821 1.8% 13F
Invesco Ltd. 1,956,614 1.3% 13F
NORTHERN TRUST CORP 1,725,693 1.1% 13F
FIRST TRUST ADVISORS LP 1,537,825 1.0% 13F
DEUTSCHE BANK AG\ 1,422,865 0.9% 13F
Swedbank AB 1,350,234 0.9% 13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,135,299 0.7% 13F
Amundi 1,062,184 0.7% 13F
NORDEA INVESTMENT MANAGEMENT AB 1,033,381 0.7% 13F
DIMENSIONAL FUND ADVISORS LP 1,004,218 0.7% 13F
GOLDMAN SACHS GROUP INC 1,004,205 0.7% 13F
Legal & General Group Plc 990,361 0.7% 13F
BANK OF AMERICA CORP /DE/ 928,430 0.6% 13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 849,070 0.6% 13F
VANGUARD FIDUCIARY TRUST CO 825,076 0.5% 13F
UBS Group AG 726,811 0.5% 13F
Caisse de depot et placement du Quebec 538,031 0.4% 13F
Pacer Advisors, Inc. 506,378 0.3% 13F
CAPTRUST FINANCIAL ADVISORS 487,861 0.3% 13F

Source：SEC EDGAR（DEF 14A・13D/G・13F）　Classification inferred from disclosed names

F-Score (Piotroski)

8/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 17.1%
✓ Positive operating cash flow $1.75B
✓ ROA improved YoY 14.9% → 17.1%
✓ Operating CF exceeds net income (accrual quality) OCF $1.75B / net income $1.40B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 70.8% → 73.0%
✓ Current ratio improved 2.59× → 3.44×
✓ No dilution (shares outstanding did not increase) 146,901,045 → 146,385,350
✓ Gross margin improved 56.7% → 59.4%
✗ Asset turnover improved 0.68× → 0.63×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 73.0%
Current ratio 3.4×
Years of positive operating CF 12 of last 12 yrs
Payout ratio 22%
Latest fiscal year result Profit (net income $1.40B)

Performance history

Last 10 years
$0.0B$1.3B$2.6B$3.9B$5.1B FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 1,8392,0672,3402,6072,9573,1973,5784,2234,6855,146
Operating income 4294265425798109041,0001,1321,3201,685
Ordinary income ——————————
Net income 3523423164056224757798981,0211,401
Total assets 3,2573,4683,0644,1084,5874,7285,0966,7526,8728,174
Equity 1,6951,9602,0592,0722,4972,8863,3614,1304,8645,968

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

*Split-adjustedUnit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS $2.51$2.42$2.21$2.83$4.31$3.27$5.34$6.12$6.94$9.55
ROE 20.8%17.5%15.3%19.5%24.9%16.4%23.2%21.7%21.0%23.5%
Operating CF 5484145054598027373516931,4011,752
Investing CF -1,126-81.9-102-1,076-180-158-230-1,160-270-200
Financing CF 613-263-1,027581-317-765-128423-1,119-606
FCF ————6966201955591,2861,651

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-03) *Some metrics supplemented from additional sources

Key financial metrics

High ROE ✓ 3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data